Next Article in Journal
Controlling Morphological Parameters of Anodized Titania Nanotubes for Optimized Solar Energy Applications
Next Article in Special Issue
Pulmonary Inflammation of Well-Dispersed Multi-Wall Carbon Nanotubes Following Intratracheal Instillation: Toxicity by Fiber of 1–5 µm in Length
Previous Article in Journal
Theory-Guided Materials Design of Multi-Phase Ti-Nb Alloys with Bone-Matching Elastic Properties
Previous Article in Special Issue
Early Combination of Material Characteristics and Toxicology Is Useful in the Design of Low Toxicity Carbon Nanofiber
Materials 2012, 5(10), 1873-1889; doi:10.3390/ma5101873

In Vivo Toxicity of Intravenously Administered Silica and Silicon Nanoparticles

Received: 3 August 2012 / Revised: 17 September 2012 / Accepted: 10 October 2012 / Published: 16 October 2012
(This article belongs to the Special Issue Nanotoxicology)
Download PDF [777 KB, uploaded 16 October 2012]


Both silicon and silica nanoparticles (SiNPs and SiO2NPs, respectively) are currently considered to be promising carriers for targeted drug delivery. However, the available data on their in vivo toxicity are limited. The present study was aimed at investigation of SiNP and SiO2NP (mean diameter 10 and 13 nm, respectively) toxicity using both morphological and functional criteria. Hematological and biochemical parameters were assessed in Sprague-Dawley rats 5, 21 and 60 days after administration of NPs. Inner ear function was determined using otoacoustic emission testing at 21 and 60 days after infusion of NPs. Furthermore, the histological structure of liver, spleen and kidney samples was analyzed. Intravenous infusion of SiNPs or SiO2NPs (7 mg/kg) was not associated with significant changes in hemodynamic parameters. Hearing function remained unchanged over the entire observation period. Both inter- and intragroup changes in blood counts and biochemical markers were non-significant. Histological findings included the appearance of foreign body-type granulomas in the liver and spleen as well as microgranulation in the liver after administration of NPs. The number of granulomas was significantly lower after administration of SiNPs compared with SiO2NPs. In conclusion, both tested types of NPs are relatively biocompatible nanomaterials, at least when considering acute toxicity.
Keywords: silicon nanoparticles; silica nanoparticles; in vivo toxicity silicon nanoparticles; silica nanoparticles; in vivo toxicity
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Ivanov, S.; Zhuravsky, S.; Yukina, G.; Tomson, V.; Korolev, D.; Galagudza, M. In Vivo Toxicity of Intravenously Administered Silica and Silicon Nanoparticles. Materials 2012, 5, 1873-1889.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Materials EISSN 1996-1944 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert